Yes. Liposomal NAD+ is better than Regular NAD+. In the health supplement industry, NAD+ is a key active ingredient. It is widely used in oral powders, tablets, capsules, and beverages. Today, there are two main types of NAD+ raw materials: Regular NAD+ powder and liposomal NAD+ powder. Many brand owners, R&D teams, and purchasing managers do not fully understand the differences between them. This can lead to poor raw material selection, lower product performance, reduced customer satisfaction, and stronger market competition. Liposomal NAD+ uses liposome encapsulation and sustained-release technology. Compared with Regular NAD+, it offers better stability, higher bioavailability, and improved product performance. It is an ideal ingredient for premium NAD+ health supplements.
Is liposomal NAD+ better than NAD+?
The answer depends on several factors. These include raw material structure, stability, absorption, bioavailability, product performance, formulation compatibility, production cost, and market competitiveness.
Differences in Raw Material Structure and Stability
The stability of the raw material is essential for health supplement production. It affects product quality, shelf life, and batch consistency. This is one of the biggest differences between Regular NAD+ and liposomal NAD+.
• Regular NAD+
Regular NAD+ is a free small molecule. It has limited resistance to acids, alkalis, and digestive enzymes. As a result, it has lower stability. During manufacturing, processing, and storage, Regular NAD+ can be affected by heat, moisture, pH, and enzymes. These factors can cause the molecule to break down and lose its activity. In oral products, Ordinary NAD+ bulk powder is quickly exposed to stomach acid. Much of the active ingredient is degraded before it reaches the absorption site. Regular NAD+ powder bulk may also lose activity during long-term storage, tablet compression, and liquid formulation. This can reduce product quality and make batch-to-batch consistency more difficult.
• Liposomal NAD+
Liposomal NAD+ powder uses phospholipid bilayer encapsulation technology. The liposome surrounds the NAD+ molecules and protects them inside its aqueous core. This protective structure improves the stability of NAD+. It helps shield the active ingredient from acids, alkalis, digestive enzymes, and temperature changes. As a result, less NAD+ is degraded before absorption. During manufacturing, liposomal NAD+ can withstand common processing steps such as mixing, tableting, and low-temperature processing. The loss of active ingredients is very low. Under sealed room-temperature storage, liposomal NAD+ powder maintains its stability for a long time. Its activity retention during shelf life is much higher than that of Regular NAD+.
Guanjie Biotech's bulk liposomal NAD+ powder is produced with a standardized liposome encapsulation process. The encapsulation efficiency is carefully controlled to ensure consistent quality from batch to batch. This makes it suitable for long-term storage and large-scale health supplement production.
Differences in Absorption Mechanism and Bioavailability
Bioavailability is a key factor that determines the effectiveness of NAD+ supplements. It directly affects product performance, customer satisfaction, and repeat purchases. It is also one of the biggest advantages of liposomal NAD+.
• Regular NAD+
Regular NAD+ is a free, water-soluble molecule with limited oral absorption. It cannot easily cross the lipid membrane of human cells and is easily degraded by stomach acid and digestive enzymes during digestion. As a result, only a small portion reaches the bloodstream, leading to low bioavailability and reduced effectiveness. To compensate for poor absorption, manufacturers often increase the dosage. However, higher doses raise production costs and may increase the risk of gastrointestinal discomfort. In addition, much of the active ingredient is wasted before it can be utilized by the body. Therefore, regular NAD+ is less efficient and provides lower cost-effectiveness for dietary supplement formulations.
• Liposomal NAD+
Liposomal NAD+ powder encapsulates NAD+ inside phospholipid liposomes, creating an advanced delivery system that greatly improves absorption. The phospholipid membrane closely resembles human cell membranes, allowing liposomes to protect NAD+ from stomach acid while delivering it efficiently through membrane fusion and endocytosis. Studies indicate that liposomal NAD+ can achieve significantly higher plasma concentrations and much greater bioavailability than regular NAD+ at the same dosage. Because more NAD+ reaches target tissues, lower dosages can deliver comparable or better results. This improves ingredient utilization, reduces gastrointestinal irritation, lowers formulation waste, and makes liposomal NAD+ an ideal ingredient for premium dietary supplements requiring high efficacy and superior performance.
Differences in Terminal Efficacy and Duration of Effect
There are clear differences in efficacy and duration between regular NAD+ and liposomal NAD+ in dietary supplements.
• Regular NAD+:
Regular NAD+ has low absorption and breaks down easily. After oral intake, only a small amount reaches the bloodstream. The active ingredient is also metabolized quickly. As a result, the effects do not last long. Products made with regular NAD+ may have slower results and less noticeable benefits. This can reduce customer satisfaction and make premium pricing more difficult. For products that support healthy aging, cellular health, and energy metabolism, regular NAD+ may not provide strong performance. It is more suitable for entry-level and cost-sensitive products.
• Liposomal NAD+:
Liposomal NAD+ offers sustained release and longer-lasting effects. After absorption, the liposome carrier gradually releases NAD+ into the bloodstream. This helps extend its circulation time and maintain a more consistent effect. Compared with regular NAD+, liposomal NAD+ may provide a longer duration of action. It also has better cellular delivery, which helps transport NAD+ to target tissues more efficiently. These advantages may support more consistent benefits for cellular health, energy metabolism, and healthy aging. Consumers are more likely to notice stable product performance, which can improve customer satisfaction and support premium positioning in the functional health supplement market.
Differences in Industrial Adaptability and Formulation Compatibility
In the industrial mass production of health supplements, the formulation compatibility and process adaptability of raw materials directly determine production efficiency and finished product qualification rate.
• Regular NAD+:
Regular NAD+ powder has limited formulation compatibility, strong water solubility, and poor stability. In complex formulation systems, it easily reacts with other functional ingredients such as vitamins, minerals, and amino acids, leading to problems such as component antagonism, activity attenuation, and system turbidity. This places high demands on formulation adjustment and production quality control. Furthermore, Regular NAD+ is not resistant to high temperatures or acids and alkalis, making it unsuitable for various processing techniques such as liquid beverages, high-temperature tableting, and solid concentrated powders. This limits product category expansion, allowing it to be used only in single dosage forms such as basic capsules and simple powders.
• Liposome NAD+:
Liposomal NAD+ offers excellent formulation compatibility and process stability for large-scale supplement production. It can be applied in oral powders, hard capsules, soft capsules, functional drinks, compressed candies, and meal replacement beverages. The liposomal structure remains stable during high-speed mixing, moderate heat processing, and different pH conditions. It is compatible with most common excipients and active ingredients, reducing formulation challenges and improving manufacturing efficiency. Guanjie Biotech's liposomal NAD+ powder has completed multiple industrial compatibility tests and performs well in refined production systems. During batch manufacturing, it maintains a high yield and avoids stratification, precipitation, and activity loss, making it suitable for multi-product and large-scale production.
Differences in Commercial Costs and Overall Cost-Effectiveness
From the perspective of the full-cycle operating costs of health supplement companies, the explicit procurement costs and implicit operating costs of the two types of raw materials show an inverse relationship.
• Regular NAD+:
Regular NAD+ has a lower unit purchase price, resulting in a significant explicit cost advantage, but its overall commercial cost-effectiveness is relatively low. Because Regular NAD+ has poor bioavailability and weak efficacy, products require high doses to achieve basic efficacy standards, resulting in high overall raw material costs. Simultaneously, poor raw material stability leads to large batch-to-batch quality fluctuations, necessitating increased quality control testing frequency and repeated formula adjustments. This results in relatively high after-sales efficacy complaint rates, leading to persistently high hidden operating costs and brand damage costs. Furthermore, Regular NAD+ products suffer from severe homogenization, intense market competition, and extremely low product premium space, limiting profit margins.
• Liposome NAD+:
While the unit price of liposomal NAD+ monomers is higher than that of Regular NAD+, resulting in higher explicit procurement costs, its overall cost-effectiveness throughout the entire product lifecycle is significantly superior. Leveraging its ultra-high bioavailability, liposomal NAD+ can achieve low-addition, high-efficacy production, significantly reducing overall raw material costs. Standardized production processes ensure high batch-to-batch quality consistency, reducing hidden costs such as formula adjustments, quality control rectification, and after-sales customer complaints. Meanwhile, liposomal NAD+ is an innovative high-end raw material in the industry, with significant product differentiation advantages. This allows it to support high-end pricing in health supplements, with a premium margin far exceeding that of Regular NAD+ products. It helps companies escape the low-price competition and enhance their core brand competitiveness and profitability. For large-scale, branded health supplement companies, the long-term commercial value of liposomal NAD+ far surpasses that of Regular NAD+.
Market Compliance and Product Competitiveness Differences:
Currently, the health supplement industry is subject to increasingly stringent regulations. Raw material compliance, efficacy, authenticity, and quality stability have become core prerequisites for product survival in the market.
• Regular NAD+:
The Regular NAD+ industry has low entry barriers. Small and medium-sized manufacturers lack standardized mass production, resulting in inconsistent raw material purity and activity indicators. Some low-end raw materials have compliance risks such as impurities and substandard activity. End products are prone to regulatory risks such as false efficacy claims and inconsistent ingredients, hindering online and offline distribution and cross-border sales. Furthermore, Regular NAD+ products have low technological barriers, severe market homogenization, and no core technological barriers, making it difficult to form a brand differentiation advantage.
• Liposome NAD+:
Liposome NAD+ is a technologically advanced raw material with more stringent production processes and quality control standards, possessing clear technological barriers and quality advantages. Guanjie Biotech's liposome NAD+ and regular NAD+ powder strictly adhere to food and health product raw material production standards, passing comprehensive quality testing and meeting the compliance standards of health products in China and over 100 countries worldwide. This makes it suitable for various compliance scenarios, including high-end domestic channels and cross-border exports. NAD+ products equipped with liposome delivery technology can leverage their core selling points of high-efficiency absorption, long-lasting efficacy, and stable quality to create a differentiated product technology label, aligning with current consumer trends towards highly effective, safe, and high-end functional health products. Their market competitiveness and sustainable operational capabilities far exceed those of regular NAD+ products.
RFQs:
1. Is liposomal NAD+ better than regular NAD+?
Yes. Liposomal NAD+ is generally considered better than regular NAD+ for oral supplements. Liposome encapsulation protects NAD+ from degradation in the digestive tract and helps improve absorption. This may result in higher bioavailability, better ingredient utilization, and longer-lasting performance. For premium dietary supplements, liposomal NAD+ offers significant advantages in stability, efficacy, and product value.
2. Why does liposomal NAD+ have higher bioavailability?
Liposomal NAD+ is enclosed in phospholipid vesicles that help protect the active ingredient from stomach acid and digestive enzymes. The phospholipid membrane is similar to human cell membranes, allowing more efficient delivery into intestinal cells. This improves absorption and enables more NAD+ to reach the bloodstream compared with conventional NAD+ powder.
3. Is liposomal NAD+ more stable during manufacturing and storage?
Yes. The liposome structure helps protect NAD+ from heat, moisture, oxygen, and pH changes. This improves ingredient stability during processing, transportation, and storage. Manufacturers can achieve better batch consistency, lower ingredient loss, and a longer shelf life than with Regular NAD+.
4. Can liposomal NAD+ be used in different supplement formulations?
Yes. Liposomal NAD+ has excellent formulation compatibility. It can be used in capsules, tablets, oral powders, stick packs, functional beverages, gummies, and other dietary supplement formats. Its improved stability also makes formulation development easier when combined with vitamins, minerals, amino acids, and other functional ingredients.
5. Does liposomal NAD+ provide longer-lasting effects?
Liposomal NAD+ is designed with a sustained-release delivery system. After absorption, the liposome gradually releases NAD+, helping maintain more consistent levels over time. Compared with regular NAD+, this may support longer-lasting benefits for cellular energy metabolism and healthy aging applications.
6. Is liposomal NAD+ worth the higher price?
Although liposomal NAD+ has a higher purchase cost, it often delivers greater overall value. Improved absorption means lower dosages may achieve similar or better performance. Higher product quality, stronger consumer satisfaction, premium pricing opportunities, and reduced manufacturing losses can improve long-term commercial returns.
7. Who should choose liposomal NAD+ instead of regular NAD+?
Liposomal NAD+ is ideal for brands developing premium dietary supplements with a focus on quality and performance. It is suitable for companies seeking differentiated products, higher customer satisfaction, better market competitiveness, and improved formulation stability. Regular NAD+ may be more appropriate for entry-level, price-sensitive products.
Summary
In summary, liposomal NAD+ offers clear advantages over Regular NAD+ for health supplement applications. The key difference lies in its advanced delivery technology, which improves stability, bioavailability, and overall performance. Regular NAD+ is suitable for low-cost, entry-level products but often provides limited absorption and weaker consumer benefits. In contrast, liposomal NAD+ delivers higher absorption, longer-lasting effects, and greater formulation flexibility. These advantages make it an ideal ingredient for premium anti-aging supplements and high-value health products in the global market.
Guanjie Biotech has deep expertise in the bulk NAD+ raw material field, and can provide health supplement companies with both standardized traditional NAD+ powder and high-quality liposome NAD+ powder. Relying on a mature R&D and production system, strict quality control processes, and global supply capabilities, it can accurately match the raw material selection and mass production needs of different companies and product lines, helping health supplement companies achieve product differentiation upgrades and market value enhancement. Welcome to enquire with us at info@gybiotech.com.
References:
[1] Kawakami, S., Maeda, Y., & Fukuzawa, Y. (2025). World's First Feat: Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide. Annals of Clinical and Medical Case Reports, *14*(2), 1-12.
[2] Kim, I., & Kim, B. S. (2024). Production of liposome loaded with nicotinamide mononucleotide using a Taylor-Couette reactor. Chemical Engineering Journal, *499*, 156194.
[3] (2024). Liposome-based loading enhances the distribution of nicotinamide riboside chloride into the brain and its neuroprotective effects in cerebral ischemic mice. Journal of Controlled Release, *368*, 110-125.
[4] (2024). Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery. Advanced Materials, *36*(5), 2307520.
[5] Li, H.-L., Xu, Y., Mo, J.-S., Zhao, X.-Y., Zhong, C.-L., & ... (2026). Single intravitreal injection of lipid nanoparticles delivering circular mRNA of nicotinamide phosphoribosyltransferase protects against dry AMD. Journal of Controlled Release, *372*, 330-345.
